You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/06/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/09/22 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 12/09/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/09/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 12/09/22 | 8-K | Current report filing |
|
   |
7 |
| 12/07/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
53 | |
| 12/07/22 | 8-K | Current report filing |
|
|
44 |
| 12/06/22 | 8-K | Current report filing |
|
|
8 |
| 12/06/22 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
53 | |
| 11/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
79 |
